Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common neurodegenerative diseases that occur either in relatively rare, familial forms or in common, sporadic forms. The genetic defects underlying several monogenic familial forms of AD and PD have recently been identified, however, the causes of other AD and PD cases, particularly sporadic cases, remain unclear. To gain insights into the pathogenic mechanisms involved in AD and PD, we used a proteomic approach to identify proteins with altered expression levels and/or oxidative modifications in idiopathic AD and PD brains. Here, we report that the protein level of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1), a neuronal de-ubiquitinating enzyme whose mutation has been linked to an early-onset familial PD, is down-regulated in idiopathic PD as well as AD brains. By using a combination of two-dimensional gel electrophoresis and mass spectrometry, we have identified three human brain UCH-L1 isoforms, a full-length form and two amino-terminally truncated forms. Our proteomic analyses reveal that the full-length UCH-L1 is a major target of oxidative damage in AD and PD brains, which is extensively modified by carbonyl formation, methionine oxidation, and cysteine oxidation. Furthermore, immunohistochemical studies show that prominent UCH-L1 immunostaining is associated with neurofibrillary tangles and that the level of soluble UCH-L1 protein is inversely proportional to the number of tangles in AD brains. Together, these results provide evidence supporting a direct link between oxidative damage to the neuronal ubiquitination/de-ubiquitination machinery and the pathogenesis of sporadic AD and PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This dysfunction contributes to neuronal damage and death by several mechanisms, including ER stress and the accumulation of oxidatively damaged proteins, which in the normal brain are usually degraded by the UPS and autophagy to keep their levels low8,50,53,55.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [55]
In the citing paper
“a crucial part of the UPS is oxidatively damaged and dysfunctional in both aMCI and AD brain, namely, ubiquitin carboxyl-terminal hydrolase L-1 (UCH L1)34,55–57.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [55]
In the citing paper
“the failure of oxidatively damaged UCH L1 to perform its function in aMCI and AD brains leads to accumulation of ubiquitinylated proteins, decreased proteasome function, and subsequent accumulation of damaged, aggregated proteins55.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [55]
Citations
Cites
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Roepstorff, P., & Fohlman, J. (1984) · Biological Mass Spectrometry · doi:10.1002/bms.1200111109 · Cited by 2,633
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Oxidant signals and oxidative stress
Finkel, T. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00002-4 · Cited by 1,393
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Methionine residues as endogenous antioxidants in proteins
Levine, R. L., Mosoni, L., Berlett, B. S., & Stadtman, E. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15036 · Cited by 1,041
The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal Hydrolase
Wilkinson, K. D., Lee, K., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., & Pohl, J. (1989) · Science · doi:10.1126/science.2530630 · Cited by 871
Research works printed but not linked: 2
- Ischiropoulos, 2003, J. Clin. Invest., 111, 163, 10.1172/jci200317638 · DOI · Paper page
- Wu, 1996, Alzheimer's Res., 2, 163
Cited by
Items 201–300 of 571
Xu, L., Li, M., Wei, A., Yang, M., Li, C., Liu, R., Zheng, Y., Chen, Y., Wang, Z., Wang, K., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02607-7 · Cited by 56
“The expression of UCHL-1 is down-regulated in early AD brains [11], and is involved in the degradation of APP and β-secretase 1 (BACE1).”
BackgroundCounts, S. E., He, B., Che, S., Ginsberg, S. D., & Mufson, E. J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1196 · Cited by 52
Halawani, D., Tessier, S., Anzellotti, D., Bennett, D. A., Latterich, M., & LeBlanc, A. C. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5874-09.2010 · Cited by 53
“Proteasome function is also compromised by the oxidation of the neuronal ubiquitin C-terminal hydrolase, UCH-L1 (Choi et al., 2004), which protects synapses against -amyloid-induced cytotoxicity (Gong et al., 2006).”
BackgroundThe aggravating role of the ubiquitin–proteasome system in neurodegeneration
Ardley, H. C., Hung, C.-C., & Robinson, P. A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.12.058 · Cited by 52
Nakamura, T., & Lipton, S. A. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402138 · Cited by 57
Free radical biology in neurological manifestations: mechanisms to therapeutics interventions
Tripathi, R. S., Gupta, R. V., Sahu, M., Srivastava, D., Das, A., Ambasta, R. K., & Kumar, P. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16693-2 · Cited by 56
“UCHL1, a member of the UCH sub-family of DUBs, is reported to be a target of FR damage in AD and PD brains (Choi et al. 2004).”
BackgroundProfiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model
McMillan, L. E., Brown, J. T., Henley, J. M., & Cimarosti, H. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.045 · Cited by 58
“the degradation of accumulated proteins are downregulated [7,19].”
Yu, X., Robinson, J. F., Sidhu, J. S., Hong, S., & Faustman, E. M. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq003 · Cited by 55
“The protein level of Uchl1 is found to be downregulated in idiopathic PD as well as Alzheimer’s disease brains (Choi et al., 2004).”
BackgroundJara, J. H., Frank, D. D., & Özdinler, P. H. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9631-7 · Cited by 55
“In addition, the number of neurofibrillary tangles was inversely proportional to the level of UCHL1 [64].”
Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice
Yokoyama, H., Takagi, S., Watanabe, Y., Kato, H., & Araki, T. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0019-6 · Cited by 53
“Furthermore, these genes may be involved in oxidative stress (Choi et al. 2004; Taira et al. 2004).”
BackgroundMuntané, G., Dalfó, E., Martínez, A., Rey, M. J., Ávila, J., Pérez, M., Portero‐Otín, M., Pamplona, R., Ayala, V., & Ferrer, I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04032.x · Cited by 56
Proteomics‐driven progress in neurodegeneration research
Fountoulakis, M., & Kossida, S. (2006) · ELECTROPHORESIS · doi:10.1002/elps.200500738 · Cited by 51
Liu, X., Zuo, H., Wang, D., Peng, R., Song, T., Wang, S., Xu, X., Gao, Y., Li, Y., Wang, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126963 · Cited by 53
“For example, recent studies showed that UCH-L1 can alleviate the Aβ-induced synaptic dysfunction and memory loss in an AD model rat[37], and a lower expression of UCH-L1 was found in AD patients[38].”
ResultEsteve-Rudd, J., Campello, L., Herrero, M. T., Cuenca, N., & Martín‐Nieto, J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.019 · Cited by 53
Di Domenico, F., Sultana, R., Ferree, A., Smith, K., Barone, E., Perluigi, M., Coccia, R., Pierce, W., Cai, J., Mancuso, C., et al. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4312 · Cited by 52
“Increased expression of oxidative markers indexed by increased malondialdehyde-lysine (MDAL) and HNE, increased oxidative damage to selected proteins, with a particular involvement of energy metabolic pathways, have been observed in the cerebral cortex in sporadic PD even at relatively early stages of the disease (9,…”
Evidence to support mitochondrial neuroprotection, in severe traumatic brain injury
Gajavelli, S., Sinha, V. K., Mazzeo, A. T., Spurlock, M. S., Lee, S. W., Ahmed, A. I., Yokobori, S., & Bullock, R. M. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9589-1 · Cited by 56
Meyer‐Schwesinger, C., Meyer, T. N., Sievert, H., Hoxha, E., Sachs, M., Klupp, E.-M., Münster, S., Balabanov, S., Carrier, L., Helmchen, U. M., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.017 · Cited by 53
Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies
Kumar, D., Ambasta, R. K., & Kumar, P. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101078 · Cited by 54
Proteomic Profiling of the Epileptic Dentate Gyrus
Li, A., Choi, Y., Dziema, H., Cao, R., Cho, H., Jung, Y. J., & Obrietan, K. H. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00414.x · Cited by 52
“Further, dysregulation of UCH-L1 has been linked to a rare form of familial early-onset Parkinson’s disease, and UCH-L1 expression is down-regulated in idiopathic forms of Alzheimer’s and Parkinson’s disease (16).”
BackgroundDi Domenico, F., Head, E., Butterfield, D. A., & Perluigi, M. (2014) · Advances in Geriatrics · doi:10.1155/2014/527518 · Cited by 50
Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer’s and related dementias
Oh, C.-K., Nakamura, T., Zhang, X., & Lipton, S. A. (2024) · Neuron · doi:10.1016/j.neuron.2024.10.013 · Cited by 56
Neuroprotective Role for Galanin in Alzheimer’s Disease
Counts, S. E., Perez, S. E., Ginsberg, S. D., & Mufson, E. J. (2010) · Experientia Supplementum · doi:10.1007/978-3-0346-0228-0_11 · Cited by 52
“Functionally, posttranslational modification of proteins by ubiquitination regulates a wide range of cellular actions including protein stability and transport [70–72].”
BackgroundNoureddine, M., Li, Y., van der Walt, J. M., Walters, R., Jewett, R. M., Xu, H., Wang, T., Walter, J. W., Scott, B. L., Hulette, C., et al. (2005) · Movement Disorders · doi:10.1002/mds.20573 · Cited by 50
Emerson, J. S., Gruenewald, S. M., Gomes, L. J., Lin, M., & Swaminathan, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1111769 · Cited by 51
“It has been associated with various pathologies, including in neurodegenerative diseases, such as Alzheimer’s or Parkinson’s diseases (108).”
BackgroundForero, D. A., Benítez, B. A., Arboleda, G., Yunis, J. J., Pardo, R., & Arboleda, H. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.04.006 · Cited by 58
“Recent studies reported that the level of soluble UCHL1 protein is inversely proportional to the number of tangles, that UCHL1 is oxidized in AD brains and that overexpression of UCHL1 reverses cognitive and synaptic deficits in an AD model (Castegna et al., 2002; Choi et al., 2004; Gong et al., 2005).”
BackgroundSignaling Molecules Involved in Lipid-Induced Pancreatic Beta-Cell Dysfunction
Shao, S., Yang, Y., Yuan, G., Zhang, M., & Yu, X. (2013) · DNA and Cell Biology · doi:10.1089/dna.2012.1874 · Cited by 52
“Mutations and modifications of UCHL1 were associated with human neurodegenerative diseases, such as Parkinson’s and Alzheimer’s diseases (Choi et al., 2004).”
BackgroundHsu, S., Lai, M., Er, T., Yang, S., Hung, C., Tsai, H., Lin, Y., Chang, J., Lo, Y., & Jong, Y. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.035 · Cited by 49
New insights into the gene expression associated to amyotrophic lateral sclerosis
Recabarren-Leiva, D., & Alarcón, M. A. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.12.016 · Cited by 55
Proteomic analysis of protein homeostasis and aggregation
Laskowska, E., Kuczyńska‐Wiśnik, D., & Lipińska, B. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.12.003 · Cited by 50
The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells
Kyratzi, E., Pavlaki, M., & Stefanis, L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn115 · Cited by 49
“Based on the fact that WT UCH-L1 is downregulated or inactivated in various neurodegenerative conditions (29), and on the restoration of neurophysiological function in an animal model of Alzheimer’s disease upon its overexpression (30), it has been proposed that strategies increasing WT UCH-L1 levels may have therapeu…”
BackgroundXue, S., & Jia, J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.121 · Cited by 52
Human IAPP amyloidogenic properties and pancreatic β-cell death
Fernández, M. S. (2014) · Cell Calcium · doi:10.1016/j.ceca.2014.08.011 · Cited by 54
Rifampicin Attenuates the MPTP-Induced Neurotoxicity in Mouse Brain
Oida, Y., Kitaichi, K., Nakayama, H., Ito, Y., Fujimoto, Y., Shimazawa, M., Nagai, H., & Hara, H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.01.116 · Cited by 47
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Wang, L., Banesh, S., Kumar, R., Schedin‐Weiss, S., Tjernberg, L. O., & Winblad, B. G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70048 · Cited by 64
“55 Specifically, there is a significant decrease in soluble UCH-L1 protein levels but an increasing trend of insoluble UCH-L1 levels in AD frontal cortex, 58 and soluble UCH-L1 protein levels are inversely proportional to NFTs numbers in AD frontal cortex.”
InfluentialThe MMACHC proteome: Hallmarks of functional cobalamin deficiency in humans
Hannibal, L., DiBello, P. M., Yu, M., Miller, A., Wang, S., Willard, B. B., Rosenblatt, D. S., & Jacobsen, D. W. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.03.008 · Cited by 47
“diseases [42–44].”
Proteomic and Mass Spectroscopic Quantitation of Protein S -Nitrosation Differentiates NO-Donors
Sinha, V., Wijewickrama, G. T., Chandrasena, R. E. P., Xu, H., Edirisinghe, P. D., Schiefer, I. T., & Thatcher, G. R. J. (2010) · ACS Chemical Biology · doi:10.1021/cb100054m · Cited by 49
Olzmann, J. A., Glausier, J. R., Muly, E. C., Rees, H. D., Levey, A. I., Li, L., & Chin, L. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21191 · Cited by 54
“Rat whole brains and human cingulate cortex, substantia nigra, and striatum were fixed in 4% paraformaldehyde and processed for immunohistochemistry as described previously (Choi et al., 2004; Olzmann et al., 2004).”
MethodSelf-citationReplaceable neurons and neurodegenerative disease share depressed UCHL1 levels
Lombardino, A. J., Li, X.-C., Hertel, M., & Nottebohm, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503239102 · Cited by 51
Mitochondria: the hidden engines of traumatic brain injury-driven neurodegeneration
Olatona, O. A., Sterben, S. P., Kansakar, S. B. S., Symes, A. J., & Liaudanskaya, V. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1570596 · Cited by 51
Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers
Wang, H., Muiznieks, L. D., Ghosh, P., Williams, D., Solarski, M., Fang, A., Ruiz‐Riquelme, A., Pomès, R., Watts, J. C., Chakrabartty, A., et al. (2017) · eLife · doi:10.7554/elife.28401 · Cited by 52
“More specifically, both Uch-L1 and RAN were reported to be downregulated in AD (Poon et al., 2013; Choi et al., 2004; Mastroeni et al., 2013), and overexpression Uch-L1 was observed to restore synaptic function in hippocampal slices treated with oAb (Gong et al., 2006).”
BackgroundNew insights on brain stem death: From bedside to bench
Chan, J. Y. H., Chang, A. Y., & Chan, S. H. H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.11.004 · Cited by 46
Barschke, P., Oeckl, P., Steinacker, P., Al Shweiki, M. R., Weishaupt, J. H., Landwehrmeyer, G. B., Anderl-Straub, S., Weydt, P., Diehl-Schmid, J., Danek, A., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322476 · Cited by 45
Explorative and targeted neuroproteomics in Alzheimer's disease
Brinkmalm, A., Portelius, E., Öhrfelt, A., Brinkmalm, G., Andréasson, U., Gobom, J., Blennow, K., & Zetterberg, H. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.01.009 · Cited by 47
Guglielmotto, M., Monteleone, D., Vasciaveo, V., Repetto, I. E., Manassero, G., Tabaton, M., & Tamagno, E. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00320 · Cited by 45
“Of note, some authors report that the activity of Uch-L1 is lower in AD brain (Pasinetti, 2001; Choi et al., 2004) and its levels are inversely proportional to the number of neurofibrillary tangles (NFT) in sporadic AD brain patients (Chen et al., 2013).”
BackgroundPatel, R. J., Brophy, C., Hickling, M., Neve, J., & Furger, A. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0509-4 · Cited by 49
UCH‐L1 expression of podocytes in diseased glomeruli and in vitro
Liu, Y., Wu, J., Wu, H., Wang, T., Gan, H., Zhang, X., Liu, Y., Li, R., Zhao, Z., Chen, Q., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2511 · Cited by 46
Bishop, P., Rubin, P. P., Thomson, A. R., Rocca, D. L., & Henley, J. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.557124 · Cited by 44
“For instance, unfolding may lead to increased association with protein aggregates, such as Lewy bodies (28) and tau tangles observed in Alzheimer disease (14).”
BackgroundResultYu, T., Zhang, P., Guan, Y., Wang, M., & Zhen, M.-Q. (2015) · Europe PMC (PubMed Central) · Cited by 62
Functional Genomics meets neurodegenerative disorders
Hoerndli, F. J., David, D. C., & Götz, J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.07.002 · Cited by 46
Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases
Do, H., & Baek, K. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101367 · Cited by 47
The Proteasome in Health and Disease
Jankowska, E., Stoj, J., Karpowicz, P., Osmulski, P. A., & Gaczynska, M. E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161281906141012124358 · Cited by 47
Proteomics in Human Parkinson’s Disease: Present Scenario and Future Directions
Dixit, A., Mehta, R., & Singh, A. K. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00700-9 · Cited by 44
Ubiquitin C-terminal hydrolase-L3 regulates EMT process and cancer metastasis in prostate cell lines
Song, H. M., Lee, J. E., & Kim, J. H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.144 · Cited by 44
“Further, the dysfunction of UCHL1 contributes to the pathogenesis of Parkinson’s disease (PD) and Alzheimer’s disease (AD) [25,26].”
BackgroundPostsynaptic Proteome of Non-Demented Individuals with Alzheimer’s Disease Neuropathology
Zolochevska, O., Bjorklund, N., Woltjer, R., Wiktorowicz, J. E., & Taglialatela, G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180179 · Cited by 42
“A deposits and NFTs with the cell loss or cognitive decline [6–10].”
BackgroundInfluentialNeurodegeneration and peroxidases
Everse, J., & Coates, P. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.007 · Cited by 45
Psychoproteomic Analysis of Rat Cortex Following Acute Methamphetamine Exposure
Kobeissy, F. H., Warren, M. W., Ottens, A. K., Sadasivan, S., Zhang, Z., Gold, M. S., & Wang, K. (2008) · Journal of Proteome Research · doi:10.1021/pr800029h · Cited by 42
Halliwell, B. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2007 · Cited by 41
Garcia‐Esparcia, P., Koneti, A., Rodríguez-Oroz, M. C., Gago, B., del Río, J. A., & Ferrer, I. (2016) · Brain Pathology · doi:10.1111/bpa.12474 · Cited by 42
“This is further supported by the identification in the frontal cortex of proteins which are damaged as a result of oxidation, including αsynuclein, β-synuclein, UCHL1, SOD1, SOD2 and DJ-1 (9, 10, 11, 12, 13, 33).”
Lee, Y.-T. C., & Hsu, S. D. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203717666160217143721 · Cited by 42
Transcriptional and post‐transcriptional regulation of β‐secretase
Tamagno, E., Guglielmotto, M., Monteleone, D., Vercelli, A., & Tabaton, M. (2012) · IUBMB Life · doi:10.1002/iub.1099 · Cited by 40
“Several lines of evidence suggest a possible link between Uch-L1 activity and AD: the activity of Uch-L1 is downregulated in AD brain (101, 102) and its levels are inversely proportional to the number of neurofibrillary tangles in the brains of sporadic AD patients (102).”
BackgroundSung, J., Cho, E., Kim, M. O., & Koh, P. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00661.x · Cited by 40
“The reduction of UCH-L1 causes synaptic deterioration and neuronal degeneration in Parkinson disease and Alzheimer s disease [37].”
BackgroundNeuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease
Mufson, E. J., Counts, S., Che, S., & Ginsberg, S. D. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)58010-0 · Cited by 40
Gu, L., & Robinson, R. A. S. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600015 · Cited by 42
“2004 Human brain tissues AD & PD 2D gel, immunostaining and MS Sulfonic acid Cys220 of UCH-L1 is oxidized to cysteic acid [160].”
BackgroundLee, S. Y., Moon, Y., Hee Choi, D., Jin Choi, H., & Hwang, O. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.024 · Cited by 40
Brown, A. M., Lemkul, J. A., Schaum, N., & Bevan, D. R. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.01.002 · Cited by 45
Oeckl, P., Steinacker, P., Arnim, C. A. F. V., Straub, S., Nagl, M., Feneberg, E., Weishaupt, J. H., Ludolph, A. C., & Otto, M. (2014) · Journal of Proteome Research · doi:10.1021/pr5006058 · Cited by 41
Inhibition of UCHL1 by LDN-57444 attenuates Ang II–Induced atrial fibrillation in mice
Bi, H.-L., Zhang, Y., Yang, J., Shu, Q., Yang, X., Xiao, Y., Chen, C., Li, Z., & Li, H. (2019) · Hypertension Research · doi:10.1038/s41440-019-0354-z · Cited by 39
Keratin mutation primes mouse liver to oxidative injury†
Zhou, Q., Ji, X., Chen, L., Greenberg, H. B., Lu, S. C.-L., & Omary, M. B. (2005) · Hepatology · doi:10.1002/hep.20578 · Cited by 39
Functional Genomics meets neurodegenerative disorders
David, D. C., Hoerndli, F. J., & Götz, J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.07.001 · Cited by 41
Nutrition: Review on the Possible Treatment for Alzheimer’s Disease
Botchway, B. O. A., Moore, M. K., Akinleye, F. O., Iyer, I. C., & Fang, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170874 · Cited by 46
Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases
Estavoyer, B., Messmer, C., Echbicheb, M., Rudd, C. E., Milot, É., & Affar, E. B. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102198 · Cited by 40
Rapid protein identification using direct infusion nanoelectrospray ionization mass spectrometry
Chen, S. (2005) · PROTEOMICS · doi:10.1002/pmic.200500043 · Cited by 38
Cai, Q., Li, B., Gao, H., Zhang, J., Wang, J., Yu, F., Yin, M., & Zhang, Z. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.110194 · Cited by 38
Liu, H., Li, W., Ahmad, M., Rose, M. E., Miller, T. M., Yu, M., Chen, J., Pascoe, J. L., Poloyac, S. M., Hickey, R. W., et al. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9377-4 · Cited by 40
“Since UCH-L1 is a component in abnormal protein aggregates found in Lewy bodies in Parkinson’s disease and neurofibrillary tangles in Alzheimer’s disease, we hypothesized that UCH-L1 also participates in 15d-PGJ2-induced Ub-protein aggregations (Choi et al. 2004).”
BackgroundChu, K. Y., Li, H., Wada, K., & Johnson, J. D. (2011) · Diabetologia · doi:10.1007/s00125-011-2323-1 · Cited by 37
Pokusa, M., & Trancikova, A. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8210734 · Cited by 39
“Furthermore, the overproduction of NO, for example because of MPTP or rotenone exposure (Figure 3), results in S-nitrosylation and the further oxidation of these proteins [128, 129, 131].”
BackgroundAssessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease
Rezaei, O., Nateghinia, S., Estiar, M. A., Taheri, M. N., & Ghafouri‐Fard, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173914 · Cited by 42
Domenico, F. D., & Lanzillotta, C. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.05.008 · Cited by 46
Sankiewicz, A., Laudański, P., Romanowicz, L., Hermanowicz, A., Roszkowska-Jakimiec, W., Dębek, W., & Gorodkiewicz, E. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.09.021 · Cited by 37
Proteomics of Human Neurodegenerative Diseases
Zhang, J., Keene, C. D., Pan, C., Montine, K. S., & Montine, T. J. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318187a832 · Cited by 39
“At least 3 of these oxidized proteins validated earlier results, including those on UCHL1-validated earlier results (41).”
Proteomic Analysis of Focal Cerebral Ischemic Injury in Male Rats
Koh, P. (2010) · Journal of Veterinary Medical Science · doi:10.1292/jvms.09-0364 · Cited by 40
“UCH-L1 attenuates neuronal cell death from oxidative stress, and a UCH-L1 decrease induces neuronal degeneration in neurodegenerative disease [5, 21].”
BackgroundGadhave, K., Kumar, P., Kapuganti, S. K., Uversky, V. N., & Giri, R. (2020) · Biomolecules · doi:10.3390/biom10050796 · Cited by 36
Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules
Lanzillotta, C., & Domenico, F. D. (2021) · Biomolecules · doi:10.3390/biom11020266 · Cited by 38
Eliuk, S. M., Renfrow, M. B., Shonsey, E. M., Barnes, S., & Kim, H. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7000948 · Cited by 36
Bogetofte, H., Jensen, P., Okarmus, J., Schmidt, S. I., Agger, M., Ryding, M., Nørregaard, P., Fenger, C., Zeng, X., Graakjær, J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104581 · Cited by 35
Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer’s disease
Ahmadi, S., Zobeiri, M., & Bradburn, S. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00564-9 · Cited by 36
“LncRNA 51A In AD, lncRNA 51A is associated with the dysregulation of the Sorting-Related Receptor 1 (SORL1) gene (Ciarlo et al. 2013).”
BackgroundRedox regulation of DUBs and its therapeutic implications in cancer
Tyagi, A., Haq, S., & Ramakrishna, S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102194 · Cited by 39
“Aberrations in UCHL1 have been associated with a number of neurodegenerative diseases, such as familial Parkinson’s disease and Alzheimer’s disease [201, 202].”
BackgroundShah, F. A., Gim, S.-A., Kim, M. O., & Koh, P. (2014) · Journal of Veterinary Medical Science · doi:10.1292/jvms.14-0169 · Cited by 36
“Moreover, it has been reported that down-regulation of UCH-L1 is associated with Parkinson’s disease and Alzheimer’s disease [8].”
BackgroundSánchez-Díaz, P. C., Chang, J. C., Moses, E. S., Dao, T., Chen, Y., & Hung, J. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176879 · Cited by 38
Choi, J.-E., Lee, J. J., Kang, W., Kim, H. J., Cho, J., Han, P., & Lee, K. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000835 · Cited by 37
“UCH-L1 also functions as an antioxidant, and it undergoes extensive oxidative modifications in neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) (15).”
BackgroundSelf-citationThe neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
van Tijn, P., Hol, E. M., van Leeuwen, F. W., & Fischer, D. F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.001 · Cited by 39
“In agreement with these observations, UCHL1 protein levels are decreased in sporadic PD and the protein is a target for oxidative damage, the latter possibly interfering with its deubiquitinating activity (Choi et al., 2004).”
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Qin, B., Chen, X., Wang, F., & Wang, Y. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02237-3 · Cited by 37
Widespread genome transcription: New possibilities for RNA therapies
Takahashi, H., & Carninci, P. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.139 · Cited by 35
NF‐κB signaling inhibits ubiquitin carboxyl‐terminal hydrolase L1 gene expression
Wang, R., Zhang, M., Zhou, W., Ly, P. T. T., Cai, F., & Song, W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07172.x · Cited by 34
“The decreased level of UCH-L1 is inversely proportional to tangle numbers in the brains of sporadic AD patients (Choi et al. 2004).”
BackgroundInfluentialRavid, R., & Ferrer, I. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08518.x · Cited by 36
Gomez, A., & Ferrer, I. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0669-y · Cited by 35
Panmanee, W., Gómez, F. J., Witte, D. P., Pancholi, V., Britigan, B. E., & Hassett, D. J. (2008) · Journal of Bacteriology · doi:10.1128/jb.00022-08 · Cited by 34
“9 474 4 (10) 7 oprD Outer membrane porin protein OprD precusor PA0958 48.”
BackgroundIdentification of the oxidative stress proteome in the brain
Sultana, R., & Butterfield, D. A. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.021 · Cited by 34
“Other proteomics studies [21,43,48], in addition to those from our laboratory, have identified oxidatively modified proteins, consistent with reported oxidative stress in neurodegenerative diseases [14,49,50].”
ResultYi, K. D., & Simpkins, J. W. (2008) · Endocrinology · doi:10.1210/en.2008-0610 · Cited by 36
Powis, R. A., Mutsaers, C. A., Wishart, T. M., Hunter, G., Wirth, B., & Gillingwater, T. H. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12168 · Cited by 35
“Down-regulation of UCHL1 has been reported in Alzheimer’s disease brains where the number of neurofibrillary tangles is inversely proportional to soluble UCHL1 levels (55).”
Metadata
- Authors
- Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Li, Lian
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 13
- Pages
- 13256-13264
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2169393803
- Cited by
- 568
- References
- 38
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 13 · 2023: 14 · 2022: 20 · 2021: 36 · 2020: 16 · 2019: 16 · 2018: 22 · 2017: 28 · 2016: 24 · 2015: 26 · 2014: 34 · 2013: 29 · 2012: 30
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6057 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30AG010130, AG-10130, AG021489, R01AG021489)
- National Cancer Institute (P30CA054174, CA-54174)
- National Institute of Neurological Disorders and Stroke (NS-047199, R01NS047199)
- National Institute of Environmental Health Sciences (ES-12068, U54ES012068)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- UCHL1, Parkinson's disease, Alzheimer's disease, protein oxidation, carbonylation, methionine oxidation, cysteine oxidation, deubiquitination, neurofibrillary tangles, protein downregulation, brain proteome
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Brain, Chromatography, High Pressure Liquid, Coloring Agents, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Molecular Sequence Data, Mutation, Oxygen, Parkinson Disease, Mass Spectrometry, Trypsin, Immunoblotting, Electrophoresis, Gel, Two-Dimensional, Down-Regulation, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Oxidative Stress, Protein Isoforms, Proteome, Ubiquitin Thiolesterase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.